medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2019, Número 1

<< Anterior Siguiente >>

Ann Hepatol 2019; 18 (1)


Challenges in Management of Hepatitis A Virus Epidemiological Transition in Mexico

Trujillo-Ochoa JL, Viera-Segura O, Fierro NA

Idioma: Ingles.
Referencias bibliográficas: 43
Paginas: 14-22
Archivo PDF: 544.84 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Martin A, Lemon SM. Hepatitis A virus: from discovery to vaccines. Hepatology 2006; 43: S164-S172.

  2. Cook N, Bertrand I, Gantzer C, Pinto RM, Bosch A. Persistence of Hepatitis A Virus in Fresh Produce and Production Environments, and the Effect of Disinfection Procedures: A Review. Food Environ Virol 2018; 10: 253-62.

  3. Chatziprodromidou IP, Bellou M, Vantarakis G, Vantarakis A. Viral outbreaks linked to fresh produce consumption: a systematic review. J Appl Microbiol 2018; 124: 932-42.

  4. Munoz-Martinez SG, Diaz-Hernandez HA, Suarez-Flores D, Sanchez-Avila JF, Gamboa-Dominguez A, Garcia-Juarez I, Torre A. Atypical manifestations of hepatitis A virus infection. Rev Gastroenterol Mex 2018; 83: 134-43.

  5. Shin EC, Jeong SH. Natural History, Clinical Manifestations, and Pathogenesis of Hepatitis A. Cold Spring Harb Perspect Med 2018; 8: a031708.

  6. Kim JD, Choi JY, Park CH, Song MJ, Jang JW, Bae SH, Yoon SK, et al. Clinical features of patients with fulminant hepatitis A requiring emergency liver transplantation: comparison with acute liver failure due to other causes. Korean J Hepatol 2010; 16: 19-28.

  7. Sotelo N, de los Angeles Durazo M, Gonzalez A, Dhanakotti N. Early treatment with N-acetylcysteine in children with acute liver failure secondary to hepatitis A. Ann Hepatol 2009; 8: 353-8.

  8. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347: 911- 20.

  9. Stuurman AL, Marano C, Bunge EM, De Moerlooze L, Shouval D. Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review. Hum Vaccin Immunother 2017; 13: 724-36.

  10. World Health Organization (WHO). Immunological Basis for Immunization Series Module 18: Hepatitis A [Internet]. WHO. [Feb 2011; cited 2018 Aug 31]. Retrieved from: http:// apps.who.int/iris/bitstream/handle/10665/44570/ 9789241501422_eng.pdf?sequence=1.

  11. Daniels D, Grytdal S, Wasley A, Centers for Disease C, Prevention. Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ 2009; 58: 1-27.

  12. Spradling PR, Xing J, Phippard A, Fonseca-Ford M, Montiel S, Guzman NL, Campuzano RV, et al. Acute viral hepatitis in the United States-Mexico border region: data from the Border Infectious Disease Surveillance (BIDS) Project, 2000-2009. J Immigr Minor Health 2013; 15: 390-7.

  13. Kumate J, Alvizouri AM, Isibasi A. Encuesta serológica de hepatitis A en niños de México. Bol Sanit Panam 1982; 92: 494-9.

  14. Secretaria de Salud (SSA). Histórico Boletín Epidemiológico. [Internet]. México:gob.mx. [Apr 2017, cited 2018 Aug 31]. Retrieved from: https://www.gob.mx/salud/acciones-y-programas/ historico-boletin-epidemiologico.

  15. Secretaría de Salud (SSA). Anuario de Morbilidad 1984- 2017. Morbilidad por Enfermedad. [Internet]. México:gob.mx. [Aug 2018, cited 2018 Aug 31]. Retrieved from: http:// w w w . epidemiologia. salud. gob. mx/anuario/html/morbilidad_enfermedad.html.

  16. Tanaka J. Hepatitis A shifting epidemiology in Latin America. Vaccine 2000; 18(Suppl. 1): S57-S60.

  17. García-Juárez I, Solórzano F, Álvarez-y-Muñoz MT, Vázquez-Rosales JG. ¿Existe transición en el patrón endémico de la hepatitis A en población infantil Mexicana? Rev Invest Clin 2008; 60: 292-6.

  18. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect 2004; 132: 1005-22.

  19. Consejo Nacional de Evaluación de la Política de Desarrollo Social (CONEVAL). Medición de la Pobreza 2008-2016. [Internet]. México:gob.mx [Aug 2018, cited 2018 Aug 31]. Retrieved from: https://www.coneval.org.mx/Medicion/Paginas/ Pobreza_2008-2016.aspx

  20. Realpe-Quintero M, Copado-Villagrana ED, Trujillo-Ochoa JL, Alvarez AH, Panduro A, Fierro NA. Cytokine Signatures Discriminate Highly Frequent Acute Hepatitis a Virus and Hepatitis E Virus Coinfections from Monoinfections in Mexican Pediatric Patients. Pediatr Infect Dis J 2017; 36: 689-92.

  21. Realpe-Quintero M, Mirazo S, Viera-Segura O, Copado-Villagrana E, Panduro A, Roman S, Arbiza J, et al. Hepatitis E Virus Genotype 1 and Hepatitis A Virus Dual Infection in Pediatric Patients with a Low Socioeconomic Status from Mexico. Intervirology 2018, in press.

  22. Escobedo-Melendez G, Fierro NA, Roman S, Maldonado- Gonzalez M, Zepeda-Carrillo E, Panduro A. Prevalence of hepatitis A, B and C serological markers in children from western Mexico. Ann Hepatol 2012; 11: 194-201.

  23. Ruiz-Gomez J, Bustamante-Calvillo ME. Hepatitis A antibodies: prevalence and persistence in a group of Mexican children. Am J Epidemiol 1985; 121: 116-9.

  24. Bustamante-Calvillo ME, Correa M, Álvarez y Muñoz MT, Ruiz-Gómez J, Muñoz HO. Etiología de la hepatitis en la ciudad de México. Bol Med Hosp Infant Mex 1986; 43: 5-10.

  25. Bustamante-Calvillo ME, Ruiz-Gomez J. Hepatitis A. II. Incidence in children 0-5 years of age. Gac Med Mex 1983; 119: 77-81.

  26. Montijo-Barrios E, García-López R, Cervantes-Bustamante R, Ramírez-Mayans J, Mata-Rivera N, Zarate-Mondragon F, Garcia-Campos M. Etiology of sudden hepatitis in children. Rev Enfer Infec Pediatr 2006; 19.20 (77).

  27. Barriga AG, Arumir EC, Mercado GF, Molina FX. Serological markers of viral hepatitis (A, B, C) in patients with acute and chronic hepatitis. Rev Mex Patol Clin 2008; 55: 143-8.

  28. Panduro A, Escobedo Melendez G, Fierro NA, Ruiz Madrigal B, Zepeda-Carrillo EA, Roman S. Epidemiology of viral hepatitis in Mexico. Salud Publica Mex 2011; 53(Suppl. 1): S37- S45.

  29. Valdespino JL, Ruiz-Gómez J, Olaiz-Fernández G, Arias-Toledo E, Conde-González EJ, Palma O, Sepulveda J. Seroepidemiology of hepatitis A in Mexico. A detector of social inequity and monitor of immunization policies. Salud Publica Mex 2007; 49(Suppl. 3): S377-S385.

  30. Gersberg RM, Rose MA, Robles-Sikisaka R, Dhar AK. Quantitative detection of hepatitis a virus and enteroviruses near the United States-Mexico border and correlation with levels of fecal indicator bacteria. Appl Environ Microbiol 2006; 72: 7438-44.

  31. Felix JL, Fernandez YC, Velarde-Felix JS, Torres BV, Chaidez C. Detection and phylogenetic analysis of hepatitis A virus and norovirus in marine recreational waters of Mexico. J Water Health 2010; 8: 269-78.

  32. Van Effelterre T, Guignard A, Marano C, Rojas R, Jacobsen KH. Modeling the hepatitis A epidemiological transition in Brazil and Mexico. Hum Vaccin Immunother 2017; 13: 1942-51.

  33. Andre FE. Approaches to a vaccine against hepatitis A: development and manufacture of an inactivated vaccine. J Infect Dis 1995; 171(Suppl. 1): S33-S39.

  34. Vizzotti C, Gonzalez J, Gentile A, Rearte A, Ramonet M, Canero- Velasco MC, Perez-Carrega ME, et al. Impact of the single- dose immunization strategy against hepatitis A in Argentina. Pediatr Infect Dis J 2014; 33: 84-8.

  35. Estripeaut D, Contreras R, Tinajeros O, Castrejon MM, Shafi F, Ortega-Barria E, De Antonio R. Impact of Hepatitis A vaccination with a two-dose schedule in Panama: Results of epidemiological surveillance and time trend analysis. Vaccine 2015; 33: 3200-7.

  36. Collier MG, Tong X, Xu F. Hepatitis A hospitalizations in the United States, 2002-2011. Hepatology 2015; 61: 481-5.

  37. Brito WI, Alves-Junior ER, Oliveira RM, Souto FJD. Initial evaluation of universal immunization with a single dose against hepatitis A virus in Central Brazil. Braz J Infect Dis 2018; 22: 166-70.

  38. Comisión Federal para la Protección contra Riesgos Sanitarios (Cofepris). Vacunas Autorizadas en Mexico. [Internet]. Mexico:gob.mx. [Nov 2017, cited 2018 Aug 31]. Retrieved from: http://www.cofepris.gob.mx/AS/Documents/Registro- Sanitario Medicamentos/Vacunas/Vacunas.pdf.

  39. Secretaría de Salud (SSA). Vacunación para Viajeros Internacionales. [Internet]. Mexico:gob.mx. [Sep 2015, cited 2018 Aug 31]. Retrieved from: https://www.gob.mx/ salud/acciones- y-programas/vacunacion-para-viajeros-internacionales.

  40. Secretaría de Salud (SSA). Manual de Vacunación, edición 2017. [Internet]. Mexico:gob.mx. [Nov 2017, cited 2018 Aug 31]. Retrieved from: https://www.gob.mx/salud%7Ccensia/ documentos/manual-de-vacunacion-edicion-2017.

  41. Van Effelterre T, De Antonio-Suarez R, Cassidy A, Romano- Mazzotti L, Marano C. Model-based projections of the population- level impact of hepatitis A vaccination in Mexico. Hum Vaccin Immunother 2012; 8: 1099-108.

  42. Chi V, Cleary S, Bocchini JA, Jr. In pursuit of control and elimination: update on hepatitis A and B epidemiology and prevention strategies. Curr Opin Pediatr 2018; 30: 689-97

  43. World Health Organization (WHO). Hepatitis A [Internet]. WHO. [Jul 2017; cited 2018 Aug 31]. Retrieved from: http:// www.who.int/news-room/fact-sheets/detail/hepatitis-a.




2020     |     www.medigraphic.com